Steroid 5 alpha-reductase 2 deficiency
Carregando...
Citações na Scopus
72
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Autores
RUSSELL, David W.
WILSON, Jean D.
Citação
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, v.163, p.206-211, 2016
Resumo
Dihydrotestosterone is a potent androgen metabolite formed from testosterone by action of 5 alpha-reductase isoenzymes. Mutations in the type 2 isoenzyme cause a disorder of 46,XY sex development, termed 5a-reductase type 2 deficiency and that was described forty years ago. Many mutations in the encoding gene have been reported in different ethnic groups. In affected 46,XY individuals, female external genitalia are common, but Mullerian ducts regress, and the internal urogenital tract is male. Most affected males are raised as females, but virilization occurs at puberty, and male social sex develops thereafter with high frequency. Fertility can be achieved in some affected males with assisted reproduction techniques, and adults with male social sex report a more satisfactory sex life and quality of life as compared to affected individuals with female social sex.
Palavras-chave
Disorders of sexual differentiation (DSD), Ambiguous genitalia, Gender identity/behavior, Androgen action, Dihydrotestosterone
Referências
- Achermann JC, 2015, NAT REV ENDOCRINOL, V11, P478, DOI 10.1038/nrendo.2015.69
- Amaral RC, 2015, CLIN ENDOCRINOL, V82, P159, DOI 10.1111/cen.12561
- ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0
- Bahceci M, 2005, UROLOGY, V66, P407, DOI 10.1016/j.urology.2005.02.021
- BOUDON C, 1995, CLIN ENDOCRINOL, V43, P183, DOI 10.1111/j.1365-2265.1995.tb01913.x
- BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P5953
- BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P2012
- Cai LQ, 1996, J CLIN ENDOCR METAB, V81, P1730, DOI 10.1210/jc.81.5.1730
- Can S, 1998, J CLIN ENDOCR METAB, V83, P560, DOI 10.1210/jc.83.2.560
- Canto P, 1997, CLIN ENDOCRINOL, V46, P155, DOI 10.1046/j.1365-2265.1997.800904.x
- Chan AOK, 2013, CLIN CHEM, V59, P798, DOI 10.1373/clinchem.2012.196501
- Chavez B, 2000, J CLIN ENDOCR METAB, V85, P3147, DOI 10.1210/jc.85.9.3147
- Cohen-Kettenis PT, 2005, ARCH SEX BEHAV, V34, P399, DOI 10.1007/s10508-005-4339-4
- Costa EMF, 2012, SEMIN REPROD MED, V30, P427, DOI 10.1055/s-0032-1324727
- Costa EMF, 1997, FERTIL STERIL, V67, P229
- Erdeve SS, 2010, EUR J PEDIATR, V169, P991, DOI 10.1007/s00431-010-1163-1
- Ferraz LFC, 1999, AM J MED GENET, V87, P221, DOI 10.1002/(SICI)1096-8628(19991126)87:3<221::AID-AJMG5>3.0.CO;2-#
- Frade Costa E M, 2001, Rev Hosp Clin Fac Med Sao Paulo, V56, P139
- FREDERIKSEN DW, 1971, J BIOL CHEM, V246, P2584
- Gad YZ, 1997, J INHERIT METAB DIS, V20, P95, DOI 10.1023/A:1005326027087
- Griffin J., 2000, METABOLIC MOL BASES
- Guercio Gabriela, 2014, Endocr Dev, V27, P87, DOI 10.1159/000363633
- Hackel C, 2005, J MOL MED-JMM, V83, P569, DOI 10.1007/s00109-005-0651-7
- Hochberg Z, 1996, J CLIN ENDOCR METAB, V81, P2821, DOI 10.1210/jc.81.8.2821
- IMPERATO.J, 1974, SCIENCE, V186, P1213, DOI 10.1126/science.186.4170.1213
- Imperato-McGinley J, 1997, Curr Ther Endocrinol Metab, V6, P384
- IMPERATOMCGINLEY J, 1991, CLIN ENDOCRINOL, V34, P293, DOI 10.1111/j.1365-2265.1991.tb03769.x
- Kang HJ, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2011.01.121
- KATZ MD, 1995, J CLIN ENDOCR METAB, V80, P3160, DOI 10.1210/jc.80.11.3160
- Katz MD, 1997, NEW ENGL J MED, V336, P994, DOI 10.1056/NEJM199704033361404
- MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784
- Maimoun L, 2011, J CLIN ENDOCR METAB, V96, P296, DOI 10.1210/jc.2010-1024
- Marzuki NS, 2010, J PEDIATR ENDOCR MET, V23, P1329, DOI 10.1515/jpem.2010.207
- Matsubara K, 2010, FERTIL STERIL, V94, DOI 10.1016/j.fertnstert.2010.04.013
- Mazen I, 2003, J PEDIATR ENDOCR MET, V16, P219
- MENDONCA B B, 1987, Revista do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, V42, P66
- Mendonca B.B., 2013, ENDOTEXT
- Mendonca BB, 1996, MEDICINE, V75, P64, DOI 10.1097/00005792-199603000-00003
- Mendonca BB, 2014, CURR OPIN ENDOCRINOL, V21, P511, DOI 10.1097/MED.0000000000000115
- Mendonca BB, 2009, CLIN ENDOCRINOL, V70, P173, DOI [10.1111/j.1365-2265.2008.03392.x, 10.1111/j.1365-2265.2008.03492.x]
- MILEWICH L, 1995, J CLIN ENDOCR METAB, V80, P3136, DOI 10.1210/jc.80.11.3136
- NG WK, 1990, ARCH DIS CHILD, V65, P1166
- Nie M, 2011, MOL HUM REPROD, V17, P57, DOI 10.1093/molehr/gaq072
- NOWAKOWSKI H, 1961, RECENT PROG HORM RES, V17, P53
- Ocal G, 2002, J PEDIATR ENDOCR MET, V15, P411
- OKON E, 1980, ARCH PATHOL LAB MED, V104, P363
- Sircili MHP, 2010, J UROLOGY, V184, P1122, DOI 10.1016/j.juro.2010.05.022
- PRICE P, 1984, J CLIN INVEST, V74, P1496, DOI 10.1172/JCI111563
- Russell DW, 2014, GENETIC STEROID DISORDERS, P199, DOI 10.1016/B978-0-12-416006-4.00014-4
- RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.biochem.63.1.25
- Sahakitrungruang T., 2015, FERTIL STERIL, V90
- Sahu R, 2009, J PEDIATR ENDOCR MET, V22, P247
- Silver RI, 1999, J UROLOGY, V162, P1142, DOI 10.1016/S0022-5347(01)68102-3
- Sircili Maria Helena Palma, 2006, Clinics, V61, P209, DOI 10.1590/S1807-59322006000300005
- Sobel V, 2006, J CLIN ENDOCR METAB, V91, P3017, DOI 10.1210/jc.2005-2809
- THIGPEN AE, 1992, J CLIN INVEST, V90, P799, DOI 10.1172/JCI115954
- Veiga-Junior N.N., 2012, INT J ENDOCRINOL, V2012
- WALSH PC, 1974, NEW ENGL J MED, V291, P944, DOI 10.1056/NEJM197410312911806
- Walter KN, 2010, HORM RES PAEDIAT, V74, P67, DOI 10.1159/000313372
- WIGLEY WC, 1994, BIOCHEMISTRY-US, V33, P1265, DOI 10.1021/bi00171a029
- WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577
- WILSON JD, 1972, NEW ENGL J MED, V287, P1284